Articles by Susan Haigney - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan Haigney

Susan Haigney

Managing Editor, Pharmaceutical Technology

Articles
Securing the Supply Chain
July 2, 2014

Regulators and industry leaders take on the task of securing the drug supply chain.

Challenges in Managing the Cold Chain
December 11, 2013

Industry experts discuss challenges in managing the cold chain.

Implementing QbD in Sterile Manufacturing
December 2, 2013

Industry experts discuss the application, challenges, and benefits of a quality-by-design approach to sterile manufacturing.

FDA Creates Partnership to Battle Anti-Malaria Counterfeit Drugs
April 24, 2013

FDA will use a new anticounterfeiting tool to detect fake medicines.

Compounding Pharmacies Recall Products
April 16, 2013

FDA inspections of compounding pharmacies manufacturing sterile-drug products lead to voluntary recalls.

FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections
April 12, 2013

FDA inspections of compounding pharmacies manufacturing sterile products reveal non-sterile conditions.

FDA Requests Almost $5 Billion for 2014 Budget
April 12, 2013

FDA's Fiscal Year 2014 budget request includes more than $10 million above the 2012 budget for inspections of products manufactured in China.

FDA Releases SUPAC Guidance
April 2, 2013

Draft guidance combines and supersedes previous guidance documents.

The Lifecycle Change of Process Validation and Analytical Testing
March 2, 2013

Industry experts discuss the effect FDA's 2011 process validation guidance has had on industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
35%
Breakthrough designations
12%
Protecting the supply chain
35%
Expedited reviews of drug submissions
12%
More stakeholder involvement
6%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here